VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $256,584 | -14.0% | 60,802 | -11.9% | 0.01% | -18.2% |
Q3 2023 | $298,192 | -3.6% | 69,026 | +47.0% | 0.01% | 0.0% |
Q2 2023 | $309,472 | +123.9% | 46,961 | +130.7% | 0.01% | +120.0% |
Q1 2023 | $138,217 | +70418.9% | 20,356 | -23.3% | 0.01% | -37.5% |
Q4 2022 | $196 | -99.9% | 26,532 | +75.7% | 0.01% | +14.3% |
Q3 2022 | $149,000 | +10.4% | 15,100 | +47.5% | 0.01% | +40.0% |
Q4 2020 | $135,000 | +36.4% | 10,239 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $99,000 | – | 10,239 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |